US 12257288
Methods of inducing immune tolerance to clotting factors
granted A61KA61K38/37A61K38/4846
Quick answer
US patent 12257288 (Methods of inducing immune tolerance to clotting factors) held by BIOVERATIV THERAPEUTICS INC. expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOVERATIV THERAPEUTICS INC.
- Grant date
- Tue Mar 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K38/37, A61K38/4846, A61P, A61P7/04